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ARTICLE
CCDC151 Mutations Cause Primary Ciliary
Dyskinesia by Disruption of the Outer
Dynein Arm Docking Complex Formation
Rim Hjeij,1,19 Alexandros Onoufriadis,2,19,21 Christopher M. Watson,3,4,19 Christopher E. Slagle,5,19
Nikolai T. Klena,6,19 Gerard W. Dougherty,1 Ma1gorzata Kurkowiak,1,7,8 Niki T. Loges,1
Christine P. Diggle,4 Nicholas F.C. Morante,5 George C. Gabriel,6 Kristi L. Lemke,6 You Li,6
Petra Pennekamp,1 Tabea Menchen,1 Franziska Konert,9 June Kehlet Marthin,10 Dorus A. Mans,11,12
Stef J.F. Letteboer,11,12 Claudius Werner,1 Thomas Burgoyne,13 Cordula Westermann,14
Andrew Rutman,15 Ian M. Carr,4 Christopher O’Callaghan,15,16 Eduardo Moya,17 Eddie M.K. Chung,18
UK10K Consortium, Eamonn Sheridan,4 Kim G. Nielsen,10 Ronald Roepman,11,12 Kerstin Bartscherer,9
Rebecca D. Burdine,5 Cecilia W. Lo,6 Heymut Omran,1,20,* and Hannah M. Mitchison2,20
A diverse family of cytoskeletal dynein motors powers various cellular transport systems, including axonemal dyneins generating the
force for ciliary and flagellar beating essential to movement of extracellular fluids and of cells through fluid. Multisubunit outer dynein
arm (ODA) motor complexes, produced and preassembled in the cytosol, are transported to the ciliary or flagellar compartment and
anchored into the axonemal microtubular scaffold via the ODA docking complex (ODA-DC) system. In humans, defects in ODA assem-
bly are the major cause of primary ciliary dyskinesia (PCD), an inherited disorder of ciliary and flagellar dysmotility characterized by
chronic upper and lower respiratory infections and defects in laterality. Here, by combined high-throughput mapping and sequencing,
we identified CCDC151 loss-of-function mutations in five affected individuals from three independent families whose cilia showed a
complete loss of ODAs and severely impaired ciliary beating. Consistent with the laterality defects observed in these individuals, we
found Ccdc151 expressed in vertebrate left-right organizers. Homozygous zebrafish ccdc151ts272a andmouse Ccdc151Snbl mutants display
a spectrum of situs defects associated with complex heart defects. We demonstrate that CCDC151 encodes an axonemal coiled coil pro-
tein, mutations in which abolish assembly of CCDC151 into respiratory cilia and cause a failure in axonemal assembly of the ODA
component DNAH5 and the ODA-DC-associated components CCDC114 and ARMC4. CCDC151-deficient zebrafish, planaria, and
mice also display ciliary dysmotility accompanied by ODA loss. Furthermore, CCDC151 coimmunoprecipitates CCDC114 and thus ap-
pears to be a highly evolutionarily conservedODA-DC-related protein involved inmediating assembly of bothODAs and their axonemal
docking machinery onto ciliary microtubules.
Introduction
Ciliary motility plays a number of essential roles in the
body.1 Notably, coordinated cilia-based fluid movement
across the multiciliated epithelial cell surface of respiratory
airways forms themajor host-defensemechanism ofmuco-
ciliary clearance.Cerebrospinal fluidflow in the central ner-
vous system is regulated by cilia lining the ventricles, and in
the reproductive system, fallopian tube cilia assist propul-
sion of eggs toward the uterus. Sperm flagella, highly struc-
turally related to cilia, drive male gamete motility. Motile
cilia function in early embryogenesis to create a leftward
nodal flow in or across vertebrate left-right organizers,
which is necessary for induction of an asymmetric gene
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expression cascade in the lateral platemesoderm that deter-
mines left-right organ asymmetry (situs).2
Motile cilia and sperm flagella extend from the cell body
containing a 9þ2 axonemal arrangement of two central
microtubules and nine peripheral microtubule doublets,
except in nodal monocilia, which lack the central micro-
tubule pair (9þ0). Microtubule-attached dynein arm mo-
tors, radial spokes, and nexin-dynein regulatory complexes
arranged with regular periodicity along the peripheral
microtubules provide a rigid structure and the biophysical
force for ciliary beating. The beat is generated by coordi-
nated sliding of adjacent microtubule doublets, powered
via dynein-arm-driven ATP hydrolysis. This axonemal ar-
chitecture is highly conserved in evolution and is found
in the biflagellate alga Chlamydomonas reinhardtii as well
as humans, where flagellar/ciliary dyneins make up two
distinct structures, the outer dynein arms (ODAs) and the
inner dynein arms (IDAs), each anchored to a specific site
on the A-tubule of the doublet microtubules. The ODAs,
with a regular spacing of 24 nm along the axonemalmicro-
tubules, contribute as much as four-fifths of the sliding
force needed for flagellar/ciliary bending.3
Primary ciliary dyskinesia (PCD [MIM 244400])4,5 refers
to an autosomal-recessive inherited disorder in which
structure and assembly of motile cilia and sperm is defi-
cient, often accompanied by visible ultrastructural defects,
resulting in dysmotile or static axonemes. PCD is charac-
terized by lifelong recurrent respiratory infections and irre-
versible, destructive airway disease (bronchiectasis) of early
onset. Otitis media and nasal polyps are common andmale
infertility may occur, as well as laterality defects affecting
approximately half of affected individuals, with around
12% manifesting as complex isomerisms and heterotaxies
usually associated with congenital heart defects.6,7 Distinct
from ultrastructural ciliary defects, CCNO (MIM 607702)
mutations have recently been identified to cause a muco-
ciliary clearance disorder related to, but distinct from,
PCD that was previously called ciliary aplasia but is now
termed RGMC (reduced generation of multiple motile
cilia), because in RGMC a few motile cilia are still detect-
able at the cell surface.8
An estimated 70%–80% of PCD cases involve deficiency
and loss of the ciliary outer dynein arms, with around
a quarter of that total also involving inner dynein arm
loss.9,10 Of 28 genes previously reported to have causative
mutations for PCD,11,12 8 encode proteins of the ODAs
or the ODA docking complex system (ODA-DC) (DNAH5
[MIM 603335], DNAH11 [MIM 603339], CCDC114 [MIM
615038], DNAL1 [MIM 610062], DNAI1 [MIM 604366],
DNAI2 [MIM 605483], NME8 [MIM 607421], and ARMC4
[MIM 615408]),13–21 mutations of which generally cause
isolated outer dynein arm deficiency. Ten genes encode
cytoplasmic proteins involved in assembly and transport
of the dynein arms into axonemes (SPAG1 [MIM 603395],
DNAAF1 [MIM 613190], DNAAF2 [MIM 612517], HEATR2
[MIM 614864], DNAAF3 [MIM 614566], DYX1C1
[MIM 608706], ZMYND10 [MIM 607070], LRRC6 [MIM
614930], C21orf59 [MIM 615494], and CCDC103 [MIM
614677]),22–32 mutations of which cause combined outer
and inner dynein arm deficiency. Eight other genes
with causal mutations are components or associated factors
of the nexin-dynein regulatory complexes (CCDC39 [MIM
613798], CCDC40 [MIM 613799], CCDC65 [MIM 611088],
and DRC1 [previously known as CCDC164] [MIM
615288]),31,33–35 radial spokes (RSPH1 [MIM 609314],
RSPH4A [MIM 612647], and RSPH9 [MIM 612648]),11,36
or central pair microtubules (HYDIN [MIM 610812]).37
Syndromic PCD with retinitis pigmentosa and develop-
mental disorders can be caused by RPGR (MIM 312610) or
OFD1 (MIM 300170) mutations38,39 and is characterized
by X-linked transmission.
Although much progress in gene identification for PCD
has been achieved, it has been recently estimated that
the known genes in which mutations cause PCD account
for about 65% of PCD cases.40 Therefore, we employed
a next-generation sequencing (NGS) approach for linkage
mapping and variant identification in order to identify
additional PCD-causing mutations. This analysis revealed
loss-of-function mutations in CCDC151 in three unrelated
families characterized by PCD with specific loss of the
ODAs. By analyzing CCDC151-deficient human cells,
mice, and zebrafish, we show a requirement for CCDC151
in the correct establishment of left-right asymmetry
because loss of CCDC151 function is associated with the
randomization of visceral organ positioning. A severe
reduction of CCDC151 occurs in the axonemes of nasal
respiratory cilia of individuals carryingCCDC151nonsense
mutations, which disrupts assembly of both the ODAs and
theODA targeting anddocking componentsCCDC114and
ARMC4 into axonemes. These results highlight the essen-
tial role of CCDC151 in the specification of ciliary motility
during human and vertebrate development.
Material and Methods
Subjects
Individuals included in the study had a clinical diagnosis of PCD
confirmed by standard clinical diagnostic criteria documenting
typical symptoms of neonatal respiratory distress and chronic res-
piratory disease features including rhinosinusitis, airway infec-
tions and fluid congestion, otitis media, and bronchiectasis.41
Clinical test results included medical imaging (X-ray); light,
electron, and immunofluorescence microscopy to detect ciliary
motility and analyze ciliary structure; and nasal nitric oxide mea-
surements. For studies of affected individuals and their families,
signed and informed consent was obtained from all participants
prior to history recording, blood drawing, and nasal biopsy, using
protocols approved by the Institutional Ethics Review Board of the
University of Muenster (Germany), the Institute of Child Health/
Great Ormond Street Hospital, London (UK) (#08/H0713/82), and
collaborating institutions.
Genetic Analysis
Next-generation sequencing was performed either by whole-
exome sequencing using the SureSelect v.5 (no UTRs) exome
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reagent (Agilent Technologies) with variant filtering performed
using the AgileExomeFilter program as previously reported42 or
by a targeted panel-based resequencing of selected candidate genes
using SureSelect RNA baits designed with the SureSelect Target
Enrichment protocol (Agilent SureDesign wizard, Agilent Technol-
ogies) with filtering as previously reported.11 Sequencing was
performed on a HiSeq 2500 in rapid run mode or HiSeq 2000
(Illumina). Sanger sequencing was performed to screen or confirm
CCDC151 mutations in affected individuals and in other family
members for segregation analysis, and details of the sequencing
primers used are available on request.
Homozygosity mapping in family 71154 used either the whole-
exome sequence data for affected individual 71154 II:2 or SNP
genotyping data generated using the Affymetrix Genome-Wide
Human SNP Array v.6.0 (Affymetrix) in both siblings 71154 II:1
and II:2. AgileMultiIdeogram, which is based on a previously
published method43 modified to use software NGS-generated
VCF rather than SAM files, was used to generate a visual output
plus numerical chromosomal coordinates for autozygous regions
of interest.
Mapping, Sequencing, and Genotyping the flanders
Locus
The flanders locus was mapped to chromosome 6 of the zebrafish
genome using a genome-wide panel of SSLP markers for low-
resolutionmapping. Finer mapping using additional SSLP markers
placed flanders in a 2.4 Mb region defined by markers z17212 and
z6601. The flanders c.631T>A mutation destroys a DraI site and
this was used to create a genotyping screen employing the primers
listed in Table S1 available online. The wild-type amplicon cut by
DraI produces a 159-bp band; the mutant amplicon not cut by
DraI is 213 bp long.
Zebrafish Microinjections
In vitro transcribed mRNAs were generated from linearized
plasmid templates using the mMessage mMachine SP6 tran-
scription kit (Ambion #AM1340) from pCS2-ccdc151 plasmid.
Translation-blocking morpholinos for ccdc151 (50-AGACCGAC
GTGCCGGGCATTATATA-30) were designed by Gene Tools, and
mRNAs were diluted in 10 mg/ml Phenol Red and injected in
500 pl drops into the yolks of 1- to 4-cell-stage embryos.
Zebrafish Microscopy
Live embryo and in situ hybridization images were captured at
43 or 103 magnifications using a ProgressC14 digital camera
(Jenoptik) on a Leica MZFLIII microscope. Brightfield video micro-
scopy of Kupffer’s vesicle and embryonic kidneys was performed
on an inverted Leica SP5 spectral confocal microscope. Live
embryos were mounted in 2% low-melt agarose in glass-bottom
tissue culture dishes and illuminated with 561 nm wavelength
light. Recordings were captured at 170 frames/s using a 633 glyc-
erin immersion objective and beat frequency was analyzed as
described.44 Histology of zebrafish embryos was performed as
described.45
Recovery of Ccdc151Snbl Mouse Mutation by
Whole-Mouse Exome Sequencing Analysis
The pathogenic mutation in the Snowball ENU mutant
(b2b1885Clo, MGI 5445347) was identified by whole mouse
exome sequence capture performed using the Agilent SureSelect
Mouse All Exon V1 kit followed by pair-end sequencing using an
Illumina HiSeq 2000 sequencer. Average 51.83 target coverage
was achieved. Reads were mapped to the C57BL/6 reference
genome (mm9) using CLCBio Genomic Workbench and GATK
v.2.8 software. Sequence variants were annotated with Annovar
and filtered against dbSNP and our in-house mouse exome data-
bases with custom scripts. Five homozygous coding variants
were obtained in the single homozygous Snbl mutant analyzed
by exome sequencing analysis. Genotyping for all five coding var-
iants in two additional Snblmutants exhibiting heterotaxy or situs
inversus totalis identified only a c.828þ2T>C Ccdc151 variant as
consistently homozygous in all of the Snbl mutant offspring.
This was further confirmed with additional breeding and geno-
typing/phenotyping analysis.
Ccdc151 Transcript Analysis in Ccdc151Snbl
Mutant Trachea
Total RNA was isolated from mouse trachea using the RNeasy Plus
Micro Kit (QIAGEN). cDNAwas synthesized from 2 mg of total RNA
and PCR amplified using AmpliTaq Gold DNA polymerase (Life
Technologies) using cycle parameters: 95C for 5 min, followed
by 40 cycles at 95C for 30 s, 58C for 30 s, and 72C for 1 min,
then 72C for 5 min. Products were analyzed by agarose gel elec-
trophoresis. Five primer pairs were used for PCR amplification to
interrogate the Ccdc151 transcript and Dnah5 was also amplified
as a positive control (primers are listed in Table S1).
Whole-Mount In Situ Hybridization
For mouse analysis, CD-1 mouse embryos were collected after
timed mating between embryonic day (E) 7.5 and E8.0 following
standard procedures. Midday on the day of plug detection was
defined as 0.5 dpc. In addition, embryos were staged by somite
counting. Sense and antisense probes for Ccdc151 were made
from a 709 bp pCRII-TOPO construct (RefSeq accession number
NM_001163787.1, nt 1031–1740, transcript variant 1) made by
TOPO TA cloning (Invitrogen) after amplification from comple-
mentary DNA. Probes were synthesized with digoxigenin NTPs
(Roche) after template linearization with HindIII (sense) or NotI
(antisense) before RNA synthesis with T7 or SP6 RNA polymerases,
respectively. For whole-mount in situ hybridization, staged em-
bryos were fixed overnight at 4C in 4% paraformaldehyde in
13 PBS. Whole-mount in situ hybridization (WISH) was then per-
formed according to standard procedures with minor modifica-
tions.27 Stained samples were transferred into 80% glycerol, and
images were captured using a Scion CFW-1310C color digital
camera mounted on an Axioskop 2 plus microscope (Zeiss) and
Image-Pro Express.
For zebrafish analysis, the full-length ccdc151 cDNA (GenBank
ID BC124606.1, Open Biosystems) was cloned using standard
methods into pCS2 for sense and antisense probe transcription,
with RNA probes transcribed from linearized plasmid templates
using DIG-labeled nucleotides and used in a standard WISH
protocol. Southpaw expression was investigated as previously
described.46
Immunofluorescence Analysis
Respiratory epithelial cells were obtained by nasal brush biopsy
(Engelbrecht Medicine and Laboratory Technology, Germany)
and suspended in cell culture medium. For mouse tracheal sam-
ples, freshly harvested trachea were placed in L-15 media (Life-
Technologies, 21083-027) and scraped with a Rhino-Probe Curette
(LabPlanet, SY-96-0925). Samples were spread onto glass slides,
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air-dried, and stored at80C until use. Cells were treated with 4%
paraformaldehyde, 0.2% Triton X-100, and 1% skimmed milk
prior to incubation with primary (2–3 hr at room temperature or
overnight at 4C) and secondary (30min at room temperature) an-
tibodies. Appropriate controls were performed by omitting the pri-
mary antibodies. Polyclonal rabbit anti-DNALI1 and anti-DNAH5
were reported previously,19 as well as the mouse monoclonal anti-
GAS8.34 Monoclonal mouse anti acetylated-a-tubulin (T7451) and
polyclonal rabbit anti-ARMC4 (HPA037829) were obtained from
Sigma. Polyclonal rabbit anti-CCDC114 (HPA042524) and anti-
CCDC151 (HPA044184) were obtained from Atlas Antibodies.
Anti-mouse Alexa Fluor 488 and anti-rabbit Alexa Fluor 546 were
used as secondary antibodies (Molecular Probes, Invitrogen).
DNA was stained with Hoechst 33342 (Sigma). Immunofluores-
cence (IF) images were taken with a Zeiss Apotome Axiovert 200
and processed with AxioVision v.4.8 and Adobe Creative Suite 4.
Mouse IF images are 3D reconstructions of z-stacks made with
the Apotome.
Cilia Transmission Electron Microscopy and Motility
Human TEM and high-speed video microscopy using the SAVA
system were performed as previously reported.19,42 TEM in mice
and zebrafish was prepared as previously reported,11 and video
microscopy was performed as previously reported.44,47–49
cDNA Cloning
CCDC114 and CCDC151 were cloned by nested PCR from human
bronchial epithelial cell cDNA (ScienCell, cat no. 3214) using KOD
polymerase according to manufacturer’s directions and recom-
bined with pDONR201 Gateway vector via BP Clonase II reaction.
Subsequently, CCDC114 and CCDC151 were subcloned into
myc and 33 FLAG epitope-tagged Gateway destination vectors
via LR Clonase reaction. All cDNA clones were confirmed by
sequence analysis and matched RefSeq gene accession number
NM_144577.3 (CCDC114) or NM_145045.4 (CCDC151).
The primers used for cDNA cloning are listed in Table S1.
Coimmunoprecipititation and Immunoblotting
HEK293 cells were transfected with plasmids encoding myc- and
FLAG-tagged cDNA constructs using Gene Juice (Novagen) at
approximately 0.1 mg DNA per ml of media. Within 24 hr, cells
were collected in 13 PBS and lysed in 1 ml of the following buffer:
50mMTris-Cl (pH 8.0), 150mMNaCl, 1% IGEPAL, 0.5mMEDTA,
and 10% glycerol supplemented with protease (Roche Complete)
and phosphatase inhibitors (Cocktails 2 and 3, Sigma Aldrich).
Lysates were centrifuged at 16,000 3 g for 30 min at 4C. Approx-
imately 2 mg of each lysate was precleared with 4 mg of rabbit con-
trol IgG antibody for 2 hr at 4C and then incubated with MagSi/
protein A beads (MagnaMedics, Germany) for 1 hr. Lysates were
then incubated with either 2 mg of rabbit anti-CCDC114 or anti-
CCDC151 antibody and 2 mg of control IgG antibody overnight
at 4C, and then incubated with MagSi/protein A beads for 1 hr
to capture immunoprecipitates. Bead complexes were washed
four times in lysis buffer and then resuspended in 13 LDS buffer
supplemented with DTT and heated for 10 min at 90C. Lysates
were electrophoresed in NuPAGE 4%–12%Bis-Tris gels, transferred
to PVDF filters, and subsequently immunoblotted with either anti-
myc (A.7) or anti-FLAG (M2) mousemonoclonal antibodies. PVDF
filters were washed three times in TBS-T (10 min each) before
blocking in 5% BSA for 2 hr at room temperature. Filters were
then washed three times (10min each) before incubation with pri-
mary antibody (diluted in TBS-T) overnight at 4C. Filters were
washed three times (10 min each) and then incubated with goat
anti-mouse HRP secondary antibody for 1 hr at room temperature.
Filters were then washed four times and developed by ECL using
Prime Western Blotting Detection Reagent (Amersham). Images
were digitally acquired using a FUSION-SL Advance Imager
(PeqLab) and modified for contrast using Adobe Photoshop
v.CS4. All wash and incubation steps were performed with gentle
shaking. The following antibodies were used: rabbit polyclonal
anti-CCDC151 (Atlas Antibodies, HPA044184), rabbit polyclonal
anti-CCDC114 (Atlas Antibodies, HPA042524), mouse mono-
clonal anti-myc (1:2,000; clone A.7, Abcam), rabbit polyclonal
control IgG (sc-2027, Santa Cruz), mouse monoclonal anti-FLAG
(1:2,000; clone M2, Sigma Aldrich), and goat anti-mouse HRP
antibody (1:5,000; NA931V, GE Healthcare).
Yeast Two-Hybrid Analysis
Direct interaction between CCDC114 and CCDC151 was tested as
previously described.27
Results
Identification of CCDC151 Mutations through
High-Throughput Autozygosity Mapping and
Sequencing
We used a high-throughput next-generation sequencing
(NGS) approach to identify PCD-causing mutations in
affected individuals that were clinically diagnosed with
PCD caused by deficiency of the axonemal ODAs. The
NGS pipeline consisted of either whole-exome sequencing
or a targetedpanel-based resequencingof selected candidate
genes,performed in twoseparate cohortsof individualswith
PCD as previously reported.11,42 NGS data were processed
through standard quality controls, and sequence reads
were aligned back to the genome and annotated for DNA
variants, which were then filtered according to a rare reces-
sive disease model11,42 (Tables S2 and S3). This excluded
genes that didnot have at least one homozygous or twohet-
erozygous changes that were either previously unreported
or occurring with an estimated frequency of less than 0.01
in publically available human exome databases (1000
Genomes,NHLBI EVS, dbSNP139). All variants except those
predicted toproduce anonsynonymousor splice-site substi-
tution, or an indel, were then removed. For the cases pro-
cessed through exome sequencing, a filter was also applied
to remove variants that were not in chromosomal regions
of interest highlighted by autozygosity mapping.
In both the resequencing panel and exome-sequence
analysis, all variants meeting the filtering criteria were
finally examined to identify those present in genes pre-
dicted to have motile cilia function. From gene panel
analysis that was conducted on 70 affected individuals,
this revealed a homozygous single-base substitution in
CCDC151 (RefSeq NM_145045.4), c.925G>T, predicting
a premature termination of translation p.Glu309*, in
a Bedouin-Arabic individual (UCL-65 II:8). The NGS
sequence filtering steps taken to reveal this predicted loss-
of-function variant as the likely disease cause are shown
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in Table S2. Individual UCL-65 II:8 also carries a single het-
erozygous variant in DNAH2 (rs7601298) and a homozy-
gous variant inDNAH3 (rs138753702), which are predicted
to be damaging to protein function, but these genes encode
inner arm dyneins.50 These and a homozygous CCDC40
variant (rs10693712), described fully in Table S2, were not
considered a possible cause of outer dynein arm loss and
furthermore were excluded as causal by segregation anal-
ysis. The other variant meeting the filtering criteria was
CCDC151 c.925G>T (p.Glu309*), which was also the only
biallelic stop-gain mutation detected.
In the exome analysis that was conducted on 28 affected
individuals, an autozygosity linkage mapping approach
was employed in consanguineous families as an extra filter
to analyze sequence variants in a narrowed set of chromo-
somal regions of interest. Genome-wide SNP genotyping
(Affymetrix human SNP Array v.6.0) identified regions of
homozygosity unique to the affected sibling in one UK-
based consanguineous family of Pakistani origin (71154).
We compared these data to SNP mapping data that could
be derived from exome sequencing, to assess its utility
for genetic mapping. We found that the information
derived from both data sets was almost identical, identi-
fying 15 autozygous regions of interest totalling 177 Mb
unique to the affected sibling 71154 II:2, including a large
autozygous region on chromosome 19p13 containing
CCDC151 (Figure S1). A homozygous CCDC151 single-
base substitution c.1256C>A was identified in individual
71154 II:2 on the basis of prioritizing these linked re-
gions, predicting a premature termination of translation
p.Ser419* (Figures 1A and 1B). The NGS sequence filtering
steps applied in family 71154 are summarized in Table S3.
Familial segregation analysis performed in available
family members showed the CCDC151 variant inheritance
pattern to be consistent for an autosomal-recessive disease
in both families, including in a second affected sibling
(UCL-65 II:7) (Figure 1A). This approach to derive auto-
zygosity linkage mapping data from polymorphic markers
and then focus on linkage-positive regions to identify
rare disease-causing variants is powerful for exome-based
gene discovery in consanguineous families, potentially
removing the need for the extra cost of SNP array analysis
in such families. Exome-sequencing-based linkage map-
ping has previously been tested for PCD51 and has proven
successful for other genetic conditions.52
CCDC151 is the vertebrate ortholog of Chlamydomonas
reinhardtii ODA10, which was recently shown to be
required for ODA assembly in these ciliated algae.53 We
therefore considered CCDC151 a reasonable PCD candi-
date gene and proceeded to screen for CCDC151mutations
by Sanger sequencing in 150 additional affected individ-
uals with ODA defects documented either by transmission
electron microscopy (TEM) or by immunofluorescence
analysis (IF). After PCR amplification and sequence anal-
ysis of all 13 exons, we identified CCDC151 mutations in
individual OP-675, who carried the same homozygous
nonsense mutation found in family UCL-65 (c.925G>T
[p.Glu309*]). Familial segregation confirmed that this
variant again segregated with the disease status in the
wider family, including in another affected sibling,
OP-1255 (Figure 1A). Neither of the two variants identi-
fied in this study, c.925G>T (p.Glu309*) or c.1256C>A
(p.Ser419*), is present in the 1000 Genomes or Exome
Variant Server databases.
In total, the mutational analysis detected CCDC151
loss-of-function nonsense mutations affecting five PCD
individuals in three families. All the affected individuals
displayed a clinical phenotype consistent with PCD
including recurrent upper and lower airway disease with
chronic respiratory symptoms and bronchiectasis, as well
as nasal blockages, polyps, and otitis media. In all but
one affected person, there was very early involvement
with neonatal respiratory distress syndrome (Table S4).
Four of the five affected individuals had laterality defects
(Figure 1C, Table S4), with a congenital cardiac defect
documented in individual OP-675 who had a ventricular
septal defect (VSD). These clinical findings suggest that
CCDC151 deficiency causes PCD and that CCDC151 func-
tion is required for correct laterality determination, which
is consistent with the known role of ODA-generated ciliary
motility in determining situs-specific morphogenesis.6
Previous studies supporting our human genetic data
have shown that the Chlamydomonas CCDC151 ortholog
ODA10 is a constituent of the flagella axoneme and
is also present in the cell body.53 The null mutant oda10
Chlamydomonas strain lacks outer dynein arms, and
ccdc151 deficiency in zebrafish knockdown morphants
also causes a specific loss of ODAs.54 Human CCDC151 en-
codes a protein of 595 amino acids, and we used SMART to
detect its domains, confirming that human CCDC151
is predicted to have three highly conserved coiled-coil
domains.Coiled-coil domains are present innumerous pro-
teins of diverse function and are recognized for their abun-
dance in transcription factors involved in cell growth and
proliferation and for their role in mediating interactions
with other proteins.55 The CCDC151mutations we identi-
fied in the PCD families are both predicted to cause prema-
ture protein truncations locatedwithin coiled-coil domains
and would likely disrupt protein function (Figure 1D).
ccdc151 Is Mutated in the Zebrafish flanders Mutant,
Leading to Ciliary Defects Including Laterality Defects
The evolutionarily conserved role of CCDC151 in verte-
brate cilia was verified by examination of zebrafish flanders
mutants. ccdc151ts272a (flanders) was generated in the
Tu¨bingen ENUmutagenesis screen.56 flandersmutants pre-
sent morphologically with a ventral body curvature and
kidney cysts (Figure 2A), characteristic of mutations that
affect ciliary motility in zebrafish. We mapped the flanders
mutation to a 2.4 Mb region on chromosome 6 and
sequenced exons from candidate genes in this region. A
c.631T>A substitution was discovered in exon 6 of
ccdc151 (RefSeq NM_001077369.2) that is predicted to
introduce a premature stop codon at lysine 211 of the
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545 amino acid protein (p.Lys211*) (Figure 2B). Consistent
with what was previously reported,54 whole mount in situ
hybridization (WISH) analysis identified ccdc151 expres-
sion restricted to tissues that contain motile cilia in zebra-
fish including the left-right organizer (Kupffer’s vesicle
[KV]), the otic vesicle, and the pronephric tubules
(Figure 2C). Further support that ccdc151 is the gene
mutated in flanders was provided by in situ hybridization
showing evidence for nonsense-mediated decay of the
transcript in embryos genotyped asmutant, which entirely
lacked expression (Figure 2D). In addition, the flanders
phenotype could be rescued by injection of ccdc151 RNA
(Figure S2), and a phenocopy of the flanders mutant
phenotype was generated by antisense morpholino injec-
tion (Figures S2 and S3).
To examine left-right patterning in flandersmutants and
ccdc151morphants, expression of the nodal gene southpaw
(spaw) and the positioning of the visceral organs (heart,
liver, and pancreas) were examined (Figure S3). Whereas
wild-type siblings express spaw in the left lateral platemeso-
derm and display situs solitus, flanders mutant embryos
and ccdc151 morphants show randomization of spaw
Figure 1. CCDC151 Recessive Loss-of-Function Mutations in Three Families with Primary Ciliary Dyskinesia and Situs Inversus
(A) Pedigree structure and segregation analysis in PCD families carrying CCDC151mutations showing an inheritance pattern consistent
with disease status, as indicated by presence of the mutant or normal (WT) alleles. Consanguineous unions OP and UCL-65 share the
same mutation, c.925G>T. Asterisks indicate situs inversus; double lines indicate first-degree consanguinity.
(B) Representative sequence traces (top) for the two CCDC151 homozygous nonsense mutations detected in affected individuals. The
examples are amplified from individual OP-675 (c.925G>T) predicting a premature termination of translation p.Glu309* and individual
71154 II:2 (c.1256C>A) predicting a premature termination of translation p.Ser419*. The normal (WT) sequence is shown below.
(C) Chest X-ray of individual OP-675 shows situs inversus totalis; R indicates right side.
(D) The location of mutations within the intron-exon structure of CCDC151 is shown above: black and white boxes indicate the coding
exons, gray the 50 and 30 UTRs. Below, the location of the mutations is shown within the corresponding 595-amino-acid CCDC151
protein (RefSeqNP_659482.3) model, predicted using SMART. Green boxes indicate coiled-coil domains; yellow boxes indicate low-com-
plexity repeat regions.
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expression, situs inversus, andheterotaxic organplacement
(Figures 2E, 2F, and S3). To explore the effect in flandersmu-
tants and ccdc151morphants on ciliary motility, cilia were
imaged using high-speed videomicroscopy in the KV and
developing kidney. In flanders mutants, cilia in the KV
moved irregularly, occasionally switching direction, or
Figure 2. Zebrafish ccdc151 Is Expressed in Ciliated Tissues and Required for Ciliary Motility-Dependent Processes
(A) Wild-type (left) and flanders (ts272a) mutant (center and right) zebrafish embryos at 48 hr postfertilization (hpf). Right panel is a
magnification of the boxed region in the center panel. Red arrow indicates pronephric cysts evident in flanders mutants.
(B) DNA sequencing chromatograms demonstrating the ccdc151 c.631T>A (p.Lys211*) nonsense mutation in flanders mutants.
(C) In situ hybridization demonstrating wild-type ccdc151 expression in Kupffer’s vesicle at tailbud stage (black arrows, top panels) and
intermediate mesoderm (black arrows), otic vesicles (red arrows), and neural tube (black arrowheads) during early (10 somites; middle
panels) and late (20 somites; bottom panels) somitogenesis.
(D) In situ hybridization demonstrating loss of ccdc151 expression in flandersmutants. Progeny of flanders/þ incrosses were sorted based
on ccdc151 expression and genotyped using the DraI restriction site destroyed by the c.631T>A (p.Lys211*) mutation.
(E) Quantification of asymmetric organ positioning in embryos at 48 hpf. flandersmutants and siblings were sorted based on body cur-
vature morphology prior to in situ hybridization. ***chi-square p value < 1055.
(F) Quantification of asymmetric expression of zebrafish nodal homolog Southpaw during somitogenesis. flanders mutants and siblings
were distinguished based on DraI restriction site presence or absence following in situ hybridization. ***chi-square p value < 109.
(G) Quantification of pronephric cilia beat frequency in flanders mutants and siblings at 48 hpf and 72 hpf. ***Student’s t test
p value < 1016.
(H) Transmission electron microscopy of cross-sections through pronephric cilia reveals the lack of outer dynein arms in embryos
injected with the ccdc151morpholino (KD¼ knockdown; blue box and arrow), compared to a wild-type uninjected embryo where outer
dynein arms (blue arrows) are visible. Scale bars represent 50 nm.
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Figure 3. Ccdc151 Localizes to Embryonic Node Monocilia and Ccdc151Snbl Mutants Exhibit a Spectrum of Laterality Phenotypes
Including Complex Congenital Heart Defects Associated with Heterotaxy
(A)Whole-mount in situ hybridization analysis ofCcdc151 in wild-type E7.5mouse embryos shows thatCcdc151 is specifically expressed
in the ventral node, marked with an asterisk in panel I showing a view from the left. Panel II shows a ventral view. Abbreviations are as
follows: A, anterior; P, posterior.
(B) Sequence of the Ccdc151Snbl homozygous mutant mouse (RefSeq NM_029939) compared to a wild-type littermate shows a
c.828þ2A>G substitution affecting the exon 6 splice donor site, with the exon-intron boundary shown by a dashed red line and intronic
sequence distinguished from exonic sequence by lower case.
(C) Transmission electron microscopy of tracheal cilia from wild-type and a Ccdc151Snbl homozygous mutant mouse reveals the lack of
outer dynein arms in the mutant (blue arrowheads). Scale bars represent 0.1 mm.
(legend continued on next page)
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were static (Movies S1 and S2). In the pronephric tubules,
ciliary motility appeared less affected because cilia were
able to bundle and beat regularly; however, themutant cilia
beat with significantly reduced beat frequency compared to
those in unaffected sibling embryos (Figures 2G and S2;
Movies S3 and S4). TEMultrastructural analysis of proneph-
ric cilia from flanders mutants revealed a loss of the ciliary
outer dynein arms (Figure 2H).
A Putative ccdc151 Ortholog Is Required for Proper
Cilia Function in Planarians
Interestingly, a putative ccdc151 ortholog (amino acid sim-
ilarity 56%; identity 33%) is also required for proper cilia
function in planarians (Figure S4). Planarians are flatworms
that move on a ventral ciliated epithelium (Figures S4A–
S4A0) and defects in cilia function cause characteristic loco-
motion defects.57 Hence, planarian locomotion represents
a simple readout for cilia dysfunction. We found that
ccdc151 RNAi-treated planarians (Figure S4C) had severely
reduced locomotive ability, moving only by contracting
theirmuscles rather thangliding (Figures S4D–S4D0;Movies
S5 and S6). TEM analysis revealed a loss of ODAs in the
mutant axonemes compared to control axonemes, consis-
tent with the findings in zebrafish and mouse CCDC151
mutants (Figure S4E). Together, thesedata support anevolu-
tionarily conserved role for ccdc151 in establishing proper
ciliary motility in vertebrates and invertebrates.
Ccdc151 Is Expressed at the Mouse Embryonic Node
and Ccdc151-Deficient Mice Exhibit Immotile and
Dyskinetic Cilia and Laterality Defects
To further examine the developmental aspects of Ccdc151
function, we performed WISH on mouse embryos exam-
ined at embryonic day E7.5 when the node is present.
This identified specific expression ofCcdc151 in the ventral
node, consistent with the zebrafish analysis (Figure 3A). To
examine the consequence ofCcdc151 deficiency on embry-
onic development, we further investigated the mouse
model using a mutant, Snowball (Snbl), which was recov-
ered from a large-scale mouse mutagenesis screen for
mutations causing congenital heart defects.58 Whole
mouse exome sequencing analysis in Snowball homozy-
gous mutants identified five homozygous coding variants
(Table S5) that were genotyped across all the mutants
from the same family. However, a single-base substitution
in the highly conserved þ2 canonical splice donor site
of Ccdc151 (RefSeq NM_029939.3) exon 6, c.828þ2A>G
(Figure 3B), was the only candidate mutation that was ho-
mozygous in all the mutants, thus indicating it is disease
causing (Table S5). This substitution causes anomalous
splicing, as shown by RT-PCR using tracheal RNA isolated
from wild-type and homozygous Snowball mutants and
primers spanning the gene, which all yielded no RT-PCR
products in Ccdc151Snbl mutants compared to controls
(Figure S5). The Ccdc151Snbl allele therefore appears to
convey a loss-of-function mutation subject to nonsense-
mediated decay similar to that of zebrafish flanders
mutants. Analysis of the tracheal airway epithelia by
high-speed videomicroscopy showed largely immotile cilia
in Ccdc151Snbl mutants as compared to the normal rapid
synchronous beating of the wild-type littermates (Movie
S7). Similarly, the ependymal cilia lining the brain ventri-
cles of mutants were largely immotile, with occasional
patches exhibiting very slow and stiff ciliary motion, while
rapid synchronous ciliary motion was observed in the
ependymal tissue of wild-type littermates (Movie S8).
TEM of tracheal cilia from homozygous mutant
Ccdc151Snbl mice showed a specific loss of the ciliary outer
dynein arms (Figure 3C). We also performed high-resolu-
tion IF microscopy of Snowball tracheal epithelia using an-
tibodies to mouse axonemal dynein heavy chain DNAH5,
which is a subunit of the ODA complexes, present in both
the distal and proximal ODA types present in respiratory
cilia.59 This showed that DNAH5 is undetectable in
Ccdc151Snbl cilia, consistent with a defect of ODA assembly
in the ciliary axonemes (Figure 3D).
Phenotyping analysis of homozygous Ccdc151Snbl
mutant animals showed a spectrum of features with three
distinct laterality phenotypes, as detailed in Table S6.
Mutants displayed either situs solitus with normal visceral
organ situs (Figure 3E, panel I), situs inversus totalis with
mirror-image symmetric organ situs (Figure 3E, panel II),
or heterotaxy with discordant or randomized organ situs
(Figure 3E, panel III). In the latter case of more complex
heterotaxy, a typical mutant exhibited normal heart orien-
tation (levocardia) and lung lobation, but inverted liver
lobation with dextrogastria (Figure 3E, panel III). Among
mutants surviving to term, 33% exhibited heterotaxy
(D) Air-dried tracheal airway epithelia from wild-type and Ccdc151Snbl mutant mice costained for acetylated a-tubulin (green) and the
ODA component DNAH5 (red) were visualized by immunofluorescence microscopy. Nuclei were stained with DAPI (blue). In control
mice, DNAH5 localized to the axonemes stained with acetylated a-tubulin (top panels), but in Ccdc151Snbl mutant airway epithelia,
DNAH5 is undetectable in the ciliary axonemes (bottom panels) Scale bars represent 10 mm.
(E) Homozygous Ccdc151Snbl mutants exhibit a spectrum of laterality defects including situs solitus (I), situs inversus totalis (II), or het-
erotaxy (III). In I–III, heart situs is denoted by arrows, lung lobation is numbered 1–5 (white numbers), and liver lobation is numbered 1–
3 (black numbers); Stm indicates stomach. Dextrocardia, inverted lung lobation, inverted liver lobation, and dextrogastria are seen in the
situs inversus totalis mutant (II) as compared to the normal visceral organ situs observed in the situs solitus mutant (I). A mutant with
heterotaxy (III) exhibits levocardia with normal heart orientation and lung lobation but inverted liver lobation and dextrogastria. Anal-
ysis of the cardiovascular anatomy of two Ccdc151Snbl mutants with heterotaxy revealed one with congenital heart defects (V)
comprising dextrocardia with duplicated inferior vena cava (IVC) and a ventricular septal defect (VSD; VIII) and another mutant heart
with a coronary artery fistula spanning from the left coronary artery to the left ventricle (VI, IX). For comparison, the heart from a normal
control animal with situs solitus is shown (IV, VII). The R-L double arrow in (I) indicates right-left orientation, which is the same for all
panels. Abbreviations: LV, left ventricle; RV, right ventricle.
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and 66% had either situs inversus or situs solitus. These
findings are consistent with observations from other
mouse models of PCD such as Dnah5, Armc4, and Dyx1c1
mutants.21,27,48 Consistent with other PCDmousemodels,
congenital heart defects observed in Ccdc151Snbl mutants
included dextrocardia with a duplicated inferior vena
cava (Figure 3E, panel V). This was confirmed by histopa-
thology examination of intracardiac anatomy with 3D
reconstruction using episcopic confocal microscopy,
which also revealed a muscular ventricular septal defect
(VSD) akin to that seen in the affected individual OP-675
carrying CCDC151 mutations (Figure 3E, panel VIII). In
another heterotaxic mutant, a coronary fistula was de-
tected by videomicroscopy of the contracting heart
(Figure 3E, panel VI and Movie S9) and confirmed by epis-
copic confocal microscopy 3D reconstruction (Figure 3E,
panel IX). As documented in detail in Table S6, in addition
to abdominal inversion and abnormal lung lobation and
bronchial branching, other heart defects were noted
including inverted outflow tract. Together, these findings
confirm Snowball to be an informative PCD mouse model.
CCDC151 Localizes to Respiratory Ciliary Axonemes
and CCDC151 Mutations Are Associated with Loss of
the Ciliary Outer Dynein Arms and Ciliary Immotility
in Humans
To further explore the role of CCDC151 in human disease,
we next examined protein localization in respiratory cili-
ated cells. We first screened protein lysates isolated from
human nasal respiratory epithelial cells using commer-
cially available rabbit polyclonal antibodies directed
against CCDC151. Immunoblot analysis showed that the
antibodies specifically recognize CCDC151, detecting a
single protein band of the predicted molecular weight
(~64 kDa) (Figure 4A). We then used this antibody to
analyze the subcellular localization of the protein in hu-
man motile respiratory cilia. IF showed that CCDC151
localizes to the axonemes of wild-type human respiratory
epithelial cells, overlapping with an acetylated a-tubulin
marker of ciliary axonemes. However, the protein was un-
detectable in the respiratory cilia of individuals OP-675
and OP-1255, consistent with the predicted loss-of-func-
tion consequences of the CCDC151 nonsense mutations
they carry (Figure 4B). We used high-speed videomicro-
scopy to analyze respiratory ciliary beating in individuals
with CCDC151 mutations. Both individuals OP-675 and
OP-1255 had completely immotile cilia compared to the
coordinated synchronous beating of cilia from unaffected
control individuals, recapitulating the functional defects
of the Ccdc151Snbl mice (Movies S10, S11, and S12).
Ultrastructural analysis by TEM of respiratory ciliary
axonemes from individuals carrying CCDC151 mutations
showed a loss of the outer dynein arms (mean of ODAs
detected: 0.8–0.9) from ciliary axonemes compared to
those of unaffected control individuals (ODA mean:
7.5–9) (Figure 5C). These results are consistent with the
Figure 4. CCDC151 Is Localized to Respiratory Ciliary Axonemes
(A) Immunoblot analysis (right lane) of protein lysates (left lane) from human respiratory cells compared to protein standard show that
CCDC151 antibodies specifically detect a single protein band corresponding to the predicted size (~64 kDa).
(B) Respiratory epithelial cells obtained by nasal biopsy of unaffected individuals and PCD-affected individuals carrying CCDC151
mutations were double labeled with antibodies directed against acetylated a-tubulin (green) and CCDC151 (red). Nuclei were stained
with Hoechst 33342 (blue). Both proteins colocalize (yellow) along the ciliary axonemes in cells from the healthy controls, while in res-
piratory cells of OP-675 and OP-1255 carrying CCDC151 recessive loss-of-function mutations, CCDC151 is not detectable in the ciliary
axonemes. Scale bars represent 10 mm.
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ultrastructural ciliary phenotype of ccdc151ts272a (flanders)
mutants, ccdc151 RNAi planarians, and Ccdc151Snbl mice
(Figures 2H, S4E, and 3C). We further examined this defect
at the molecular level by immunofluorescence staining of
the respiratory cells of individuals OP-675 and OP-1255 us-
ing antibodies directed against two established markers of
human dynein arm integrity, the ODAmarker DNAH5 and
IDA marker DNALI1 (which is a light intermediate dynein
associated with some IDAs). DNAH5 was undetectable in
the axonemes of CCDC151mutant individuals, suggesting
that CCDC151 deficiency likely causes a disruption of
axonemal ODA assembly (Figure 5A). In contrast, DNALI1
correctly localized to the axonemes of both individuals’
respiratory cells. This marker showed a similar distribution
to that of control individual’s cilia (Figure 5B), suggesting
that CCDC151 mutations do not alter assembly of IDA
proteins.
Together, the TEM and IF data indicate that the axo-
nemes of CCDC151-deficient cilia have ODA defects but
that DNALI1-related IDA assembly is undisturbed. We
also examined the integrity of the ciliary nexin dynein reg-
ulatory complexes (N-DRC) in CCDC151 mutant cilia by
immunolocalization using antibodies directed against an
integral N-DRC component, GAS8 (human DRC4).33–35
Similarly to DNALI1, GAS8 correctly localized to mutant
ciliary axonemes, indicating that N-DRC assembly is not
affected (Figure 5B).
CCDC151 Plays a Role in Assembly of the Outer
Dynein Arm Docking Complex in Addition to Its Role
in Outer Dynein Arm Assembly
To further understand the functional role of CCDC151
in ODA assembly, we also studied the localization of
CCDC114, which is an ODA-DC subunit responsible for
axonemal microtubule attachment of the ODAs16 in
CCDC151 mutant cilia. We found that CCDC114 was un-
detectable in the respiratory cilia of CCDC151-mutant in-
dividuals compared to the normal axonemal localization
of CCDC114 in respiratory cilia from unaffected controls
(Figure 6A). This suggests that the axonemal localization
of CCDC114 is CCDC151 dependent. Since the locali-
zation of the ODA-DC-related ARMC4 is known to
be CCDC114 dependent,21 we also studied ARMC4 locali-
zation in CCDC151 mutant cilia. ARMC4 was also unde-
tectable in the respiratory cilia of CCDC151 mutant
individuals, indicating that similarly to CCDC114, the
axonemal localization of ARMC4 is CCDC151 dependent
(Figure 6B).
Considering the similarities in phenotype caused by
CCDC114 and CCDC151 mutations with regard to ODA
defects,16 we tested for possible interactions between
these proteins. Using myc- and FLAG-tagged proteins
that were coexpressed in HEK293 cells, we found by
coimmunoprecipitation that CCDC151 interacted with
CCDC114 (Figure 6C), but not DNAI1, DNAI2, and
DNAL1, whose mutations also cause ODA defects (data
not shown). We confirmed the reciprocal interaction
between CCDC114 and CCDC151 by yeast two-hybrid
analysis (Figure S6).
Discussion
In this study, we describe loss-of-function nonsense muta-
tions in CCDC151 in five individuals with PCD from three
unrelated families. CCDC151 is a coiled-coil-domain-con-
taining protein conserved in motile ciliated species, and
the Chlamydomonas ortholog ODA10 has recently been
described as critical for axonemal motility.53 CCDC151
was also recently shown to be critical for motility of intra-
flagellar (IFT)-dependent cilia in Drosophila and expressed
in motile cilia of zebrafish.54 The identified human
CCDC151 mutations are predicted to result in the failure
to produce a functional CCDC151, and this was verified
by immunofluorescence studies on nasal respiratory
epithelial cilia of affected individuals.
In humans, we find that CCDC151 deficiency causes
PCD with randomization of left-right body asymmetry.
This is consistent with evidence from zebrafish showing
that ablation of ccdc151 in flandersmutants as well as mor-
pholino-induced ccdc151 depletion leads to a randomiza-
tion of left-right body asymmetry, as reported here and
in a prior study.54 Similarly, we find that homozygous
mutant Ccdc151Snbl mice display laterality defects ranging
from situs inversus to a spectrum of situs anomalies asso-
ciated with heterotaxy. Also consistent with these data
is the finding that the zebrafish and mouse orthologs of
CCDC151 are expressed in left-right organizers during
embryonic development. The Ccdc151Snbl mutants with
heterotaxy manifested with congenital heart defects, dis-
playing intracardiac anomalies including inverted outflow
tract, ventricular septal defects, and dual inferior vena
cava. A variable displacement of other visceral organs
(liver, gut, abdomen) was also observed, as well as
abnormal lung lobation and bronchial branching. This
mirrors the laterality phenotypes recorded in all but one
of the five individuals carrying CCDC151 mutations that
are reported here.
In CCDC151 mutant human cilia, we found that the
ODA component DNAH5 is not detectable in the ciliary
axonemes, indicating that CCDC151 deficiency leads to
defects of both known ODA types present in the proximal
and distal ciliary axonemes.59 This is confirmed by the
absence of ODAs in ultrastructurally analyzed cross-sec-
tions from CCDC151 mutant cilia, corresponding to the
ciliary immotility observed by high-speed video micro-
scopy. In agreement with these data, CCDC151-deficient
Chlamydomonas, fly, zebrafish (flanders and morphants),
planarians, and Ccdc151Snbl mice all have defective ciliary
motility associated with a lack of axonemal ODAs.53,54 In
contrast, we found that the axonemal IDA component
DNALI1 was normal in CCDC151 mutant cilia, suggesting
that CCDC151 deficiency does not result in defects of IDA
axonemal assembly.
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Figure 5. CCDC151 Mutations Result in Defects of the Outer Dynein Arms
(A) Respiratory epithelial cells from control and PCD-affected individuals OP-675 and OP-1255 carrying CCDC151mutations were dou-
ble-labeled with antibodies directed against acetylated a-tubulin (green) and DNAH5 (red). Both proteins colocalize (yellow) along the
cilia in cells from the unaffected control. In contrast, in CCDC151 mutant, DNAH5 is not detectable in the ciliary axonemes.
(legend continued on next page)
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Using an antibody that specifically detects the native
CCDC151 in human respiratory epithelial cells, we found
a predominantly axonemal localization of CCDC151.
These results contrast with previous reports from studies
in Chlamydomonas and Drosophila chordotonal neuron
cilia that showed dual localization for CCDC151 orthologs
in both the cilia/flagella and cytosolic compartments.53,54
These reported studies were based on overexpression of
epitope-tagged forms of CCDC151, and it is possible that
human cilia do contain cytosol-localized CCDC151 but
at levels below our IF detection ability. Mutations causing
PCD have been found in a number of cytosolic and
cytosolic/axonemal dual localized factors, at least some
of which are known to be involved in the preassembly
of the ciliary dynein motors within the cell body prior
to their import into cilia (SPAG1, DNAAF1, DNAAF2,
HEATR2, DNAAF3, DYX1C1, ZMYND10, LRRC6,
C21orf59, and CCDC103).22–32 However, causal mutations
in this class of protein have so far all been associated with
combined ODA and IDA deficiency, which is distinct from
the isolated ODA deficiency arising from CCDC151 muta-
tions. Therefore, despite axonemal and cytoplasmic coloc-
alization for CCDC151 suggested from model systems,
CCDC151 is not likely to function as a ‘‘typical’’ cyto-
plasmic dynein arm assembly factor.
Here, we found that CCDC114 and ARMC4 are unde-
tectable in the ciliary axonemes of CCDC151 mutant
individuals, indicating that their ciliary localization is
CCDC151 dependent. Moreover, we demonstrate that
CCDC151 and CCDC114 interact together by coimmuno-
precipitation analyses. Fundamental to the process of as-
sembly and attachment of the dynein arms into axonemes
is the correct targeting and docking of the ODAs via the
ODA docking complex (ODA-DC) system, and human
CCDC114 and ARMC4 have been implicated as integral
or associated ODA-DC proteins, representing essential
components for attachment of ODAs into ciliary axo-
nemes. Furthermore, mutations in ARMC4 and CCDC114
cause PCD with outer dynein arm defects similarly to the
CCDC151 mutations reported here.15,16,21,60,61 CCDC114
is the vertebrate ortholog of the Chlamydomonas ODA-
DC component DC2.15,16 Chlamydomonas has two other
ODA-DC proteins, the coiled-coil DC1 and the EF-hand
DC3/DLE3,62,63 which still have no defined vertebrate or-
thologs. The armadillo-repeat ARMC4 has been shown to
be CCDC114 dependent for its localization into axonemes
and to be involved in the correct targeting and docking of
the ODAs.21 These data therefore suggest that CCDC151 is
required for assembly of ODAs as well as ODA-DCs into
axonemes.
Recent work showing that the Chlamydomonas ortholog
of CCDC151, ODA10, is not an integral ODA component
but is required for ODA assembly53 add to growing evi-
dence for the existence of an accessory complex to the
ODA-DC in Chlamydomonas that is independent from
the ODA-DC. This ODA-DC accessory complex is thought
to be composed of three subunits: ODA10 in addition to
ODA5 and ODA8.64–66 It can thus be considered unlikely
that human CCDC151 is a structural component of the
ODAs or the ODA-DCs themselves. Rather, the loss of
CCDC114 and ARMC4 from CCDC151-mutated cilia and
the direct interaction between CCDC151 and CCDC114
point to a role for CCDC151 in the assembly or other activ-
ities of the ODA docking complex. Chlamydomonas studies
have shown that ODA10/CCDC151 might have a role in
converting the ODAs into a form with higher binding af-
finity for their axonemal binding sites, and hence acting
at a key step in the final association of dynein complexes
with their docking sites.53
Multisubunit axonemal dynein arm complexes contain
heavy, intermediate, and light chain dyneins, and dyneins
form a diverse protein family with roles in many different
types of cellular movement, such as vesicle transport, nu-
clear migration, chromosome movements, spindle forma-
tion and orientation, and beating of cilia and flagella.67
The correct attachment of specific dyneins to different
cell structures plays a major role in the maintenance of
many essential cell functions.68 Therefore, dissecting out
the mechanisms by which dyneins are targeted to and
bind to cell organelles are of substantial interest. Current
evidence suggests that CCDC151 is an atypical PCD-asso-
ciated protein, probably not an integral component of
the ODA-docking complex but required for correct
axonemal docking and targeting of ODAs and essential
for the assembly of both the ODAs and the ODA-DC
apparatus.
Discovery of additional causal mutations underlying
PCD has clinical significance for improving genetic and
clinical diagnosis of this condition and facilitating
improved counselling of affected families. In one consan-
guineous family (71154), we identifiedmutations after first
narrowing down the regions of interest for gene identifica-
tion by mapping autozygous regions of interest. Here,
using whole-exome sequencing output to provide a
combined mapping/sequencing use of NGS data proves a
powerful approach for discovery of PCD-causing muta-
tions, which often affects consanguineous families.69
CCDC151mutations appear to be a rare cause of PCD since
next-generation sequencing of collectively more than 280
affected individuals by the London and Leeds group has
(B) Respiratory epithelial cells from control and PCD-affected individuals OP-675 and OP-1255 carrying CCDC151mutations were dou-
ble-labeled with antibodies directed against the N-DRC component GAS8 (green) and DNALI1 (red). Both proteins colocalize (yellow)
along the cilia in cells from the unaffected control as well as both of the PCD-affected individuals. Scale bars represent 10 mm.
(C) Transmission electron micrographs of cross-sections through respiratory epithelial cell cilia show an absence of the outer dynein
arms in PCD-affected individuals withCCDC151mutations (right panels, blue box and arrow), compared to a control individual without
PCD. In the healthy control, outer dynein arms (left panel, blue arrows) are visible. Scale bars represent 0.1 mm.
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Figure 6. Mutations in CCDC151 Affect the Localization of ODA-Microtubule Docking-Complex-Associated Components CCDC114
and ARMC4 in Human Respiratory Cells and the ODA-Associated CCDC151 Interacts with CCDC114
(A and B) Respiratory epithelial cells from an unaffected control and PCD-affected individuals carrying CCDC151mutations were dou-
ble-labeled with antibodies directed against acetylated a-tubulin (green) and CCDC114 (A, red) or ARMC4 (B, red). CCDC114 and
(legend continued on next page)
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detected only two affected families, and only one further
affected family was detected out of 150 displaying ODA
defects that were screened in Germany. The c.925G>T
nonsense variant was detected in two unrelated pedigrees
of Arabic origin. We cannot rule out a founder mutation,
because we were not able to compare haplotypes. ODA as-
sembly and docking are complex molecular mechanisms
that should be studied in more depth in order to identify
therapeutic approaches for treatment of individuals
affected with PCD. Thus the identification of mutations
in CCDC151 provides an important step forward in under-
standing the complex biology of ODA assembly in motile
cilia and flagella.
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